Form 4: Ennis, Inc. Director Michael J. Schaefer Reports Stock Grant
SEC Form 4 Filing
Director Michael J. Schaefer reported the acquisition of 2,485 shares of Ennis, Inc. common stock through a restricted stock grant.
Summary
- On July 18, 2024, Michael J. Schaefer, a director of Ennis, Inc., acquired 2,485 shares of common stock.
- The acquisition was a result of a restricted stock grant.
- The shares were acquired at a price of $0.
- Following the transaction, Schaefer directly owns 59,599 shares of Ennis, Inc.
- The restricted stock grant vests in three equal annual installments, starting on the first anniversary of the grant date.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a stock grant to a director, which is neither particularly positive nor negative.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The restricted stock grant vests in three equal annual installments, commencing on the first anniversary of the grant date.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a grant of restricted stock to a director, which is a common form of executive compensation.
Stakeholder Impact
- The stock grant could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/18/2024 | Date of transaction: Michael J. Schaefer acquired 2,485 shares of Ennis, Inc. common stock. |
| 07/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.